| LDR | | 03147cmm u22006618i 4500 |
| 001 | | 000000327859 |
| 003 | | OCoLC |
| 005 | | 20240307140733 |
| 006 | | m d |
| 007 | | cr ||||||||||| |
| 008 | | 171102s2017 dcu ob 000 0 eng |
| 010 | |
▼a 2017053059 |
| 019 | |
▼a 1393242461
▼a 1396697982
▼a 1396791119
▼a 1397477777 |
| 020 | |
▼a 9781947103115
▼q (Ebook) |
| 020 | |
▼a 9780309705363
▼q (electronic bk.) |
| 020 | |
▼a 0309705363
▼q (electronic bk.) |
| 020 | |
▼a 1947103113 |
| 020 | |
▼z 9781947103108
▼q (pbk.) |
| 020 | |
▼a 030970538X |
| 020 | |
▼a 9780309705387
▼q (electronic bk.) |
| 020 | |
▼z 0309705355 |
| 020 | |
▼z 9780309705356 |
| 035 | |
▼a 3661360
▼b (N$T) |
| 035 | |
▼a (OCoLC)1010537042
▼z (OCoLC)1393242461
▼z (OCoLC)1396697982
▼z (OCoLC)1396791119
▼z (OCoLC)1397477777 |
| 040 | |
▼a DLC
▼b eng
▼e rda
▼c DLC
▼d OCLCO
▼d OCLCA
▼d OCLCQ
▼d OCLCO
▼d N$T
▼d OCLCO
▼d YDX
▼d EBLCP
▼d SMC
▼d 248032 |
| 042 | |
▼a pcc |
| 049 | |
▼a MAIN |
| 050 | 4 |
▼a RC568.O45 |
| 050 | 10 |
▼a RC568.O58 |
| 060 | 10 |
▼a WM 284 |
| 082 | 04 |
▼a 615.7/822
▼2 23/eng/20231222 |
| 082 | 00 |
▼a 616.86/32
▼2 23 |
| 130 | 0 |
▼a First, do no harm (National Academy of Medicine) |
| 245 | 10 |
▼a First, do no harm :
▼b marshaling clinician leadership to counter the opioid epidemic. |
| 263 | |
▼a 1711 |
| 264 | 1 |
▼a Washington, DC :
▼b National Academy of Medicine,
▼c [2017] |
| 264 | 4 |
▼c 짤2017 |
| 300 | |
▼a 1 online resource |
| 336 | |
▼a text
▼b txt
▼2 rdacontent |
| 337 | |
▼a computer
▼b c
▼2 rdamedia |
| 338 | |
▼a online resource
▼b cr
▼2 rdacarrier |
| 504 | |
▼a Includes bibliographical references. |
| 505 | 0 |
▼a Intro -- Title Page -- Copyright Page -- Table of Contents -- Foreword -- Introduction -- What Is the Magnitude of the Opioid Epidemic? -- Which Opioids Are Most Commonly Involved in Overdose Deaths? -- What Are the Associated Characteristics of Those with Opioid Use Disorder? -- How Does the Opioid Epidemic Impact Our Families and Our Communities? -- What Has Driven the Epidemic? -- Are Effective Pain Management and Opioid Crisis Mitigation Competing Priorities? -- What Guidance and Assistance Is Available from Professional and Policy Organizations? |
| 505 | 8 |
▼a What Are Primary Clinician Opportunities to Counter the Opioid Epidemic and Its Consequences? -- Summary Messages: Calling the Nationa??р꽓s Clinicians to Action -- References -- Appendix A: Action Resources -- Appendix B: Author Biosketches |
| 588 | 0 |
▼a Print version record. |
| 590 | |
▼a OCLC control number change |
| 650 | 0 |
▼a Opioid abuse. |
| 650 | 12 |
▼a Prescription Drug Misuse
▼x adverse effects |
| 650 | 12 |
▼a Opioid-Related Disorders
▼x prevention & control |
| 650 | 22 |
▼a Pain Management
▼x adverse effects |
| 650 | 22 |
▼a Physician's Role |
| 650 | 2 |
▼a Opioid-Related Disorders |
| 650 | 6 |
▼a Toxicomanie aux opiace?s. |
| 710 | 2 |
▼a National Academy of Medicine (U.S.),
▼e issuing body. |
| 776 | 08 |
▼i Print version:
▼d Washington, DC : National Academy of Medicine, 2017
▼z 9781947103108
▼w (DLC) 2017052761 |
| 856 | 40 |
▼3 EBSCOhost
▼u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3661360 |
| 938 | |
▼a EBSCOhost
▼b EBSC
▼n 3661360 |
| 990 | |
▼a 관리자 |
| 994 | |
▼a 92
▼b N$T |